(MMI) Marcus & Millichap - Ratings and Ratios
Brokerage, Financing, Research, Advisory, Capital Markets
MMI EPS (Earnings per Share)
MMI Revenue
Description: MMI Marcus & Millichap
Marcus & Millichap Inc (NYSE:MMI) is a leading investment brokerage firm specializing in commercial real estate services, including investment sales, financing, research, and advisory services, catering to a diverse range of property types and clients across the United States and Canada. The companys comprehensive suite of services positions it as a one-stop-shop for commercial real estate owners, developers, and investors, providing them with expert guidance on transactions, capital markets, and strategic advisory needs.
The companys role as a financial intermediary is particularly noteworthy, as it offers a range of capital markets solutions, including debt financing options, equity partnerships, and securitization services, thereby facilitating the flow of capital into the commercial real estate market. Additionally, Marcus & Millichaps advisory and consulting services provide valuable insights and analysis to clients, helping them navigate the complexities of the commercial real estate landscape and make informed decisions.
With a strong foundation established in 1971 and headquartered in Calabasas, California, Marcus & Millichap has developed a robust presence in the commercial real estate industry. Its expertise spans various property types, including multifamily, retail, office, industrial, and hospitality, among others. The companys website (https://www.marcusmillichap.com) serves as a resource for clients and industry professionals seeking information on commercial real estate trends, market analysis, and the companys services.
Analyzing the provided
Forecasting the stocks performance based on the available data, we can hypothesize that if the company can stabilize its financial performance and potentially return to profitability, the stock might experience a rebound. A key factor to watch would be the companys ability to navigate the challenges in the commercial real estate market and maintain its market share. Technically, a break above the 50-day SMA could signal a short-term positive trend, while a sustained move above the 200-day SMA would be a stronger bullish indicator. Conversely, failure to gain traction and continued downward pressure could lead to further declines, potentially testing the 52-week low of $28.00. Therefore, investors should closely monitor both the companys financial health and the overall market conditions to make informed decisions.
MMI Stock Overview
Market Cap in USD | 1,256m |
Sector | Real Estate |
Industry | Real Estate Services |
GiC Sub-Industry | Real Estate Development |
IPO / Inception | 2013-10-31 |
MMI Stock Ratings
Growth Rating | -12.6 |
Fundamental | 28.2% |
Dividend Rating | 1.93 |
Rel. Strength | -25.1 |
Analysts | 1.00 of 5 |
Fair Price Momentum | 25.18 USD |
Fair Price DCF | 1.02 USD |
MMI Dividends
Dividend Yield 12m | 1.52% |
Yield on Cost 5y | 1.96% |
Annual Growth 5y | -30.66% |
Payout Consistency | 78.5% |
Payout Ratio | 135.1% |
MMI Growth Ratios
Growth Correlation 3m | 66.3% |
Growth Correlation 12m | -75.5% |
Growth Correlation 5y | -5.5% |
CAGR 5y | 2.70% |
CAGR/Max DD 5y | 0.05 |
Sharpe Ratio 12m | -0.13 |
Alpha | -45.65 |
Beta | 1.051 |
Volatility | 32.14% |
Current Volume | 162.4k |
Average Volume 20d | 108.1k |
Stop Loss | 27.9 (-4%) |
Piotroski VR‑10 (Strict, 0-10) 3.0
Net Income (-6.80m TTM) > 0 and > 6% of Revenue (6% = 42.7m TTM) |
FCFTA 0.02 (>2.0%) and ΔFCFTA 11.54pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 33.55% (prev 40.46%; Δ -6.91pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.02 (>3.0%) and CFO 19.9m > Net Income -6.80m (YES >=105%, WARN >=100%) |
NO Net Debt/EBITDA fails (EBITDA <= 0) |
Current Ratio 3.77 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (38.9m) change vs 12m ago 1.26% (target <= -2.0% for YES) |
Gross Margin 37.32% (prev 36.34%; Δ 0.98pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 87.43% (prev 75.03%; Δ 12.40pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio -22.95 (EBITDA TTM -2.34m / Interest Expense TTM 800.0k) >= 6 (WARN >= 3) |
Altman Z'' 6.13
(A) 0.30 = (Total Current Assets 325.1m - Total Current Liabilities 86.2m) / Total Assets 802.0m |
(B) 0.55 = Retained Earnings (Balance) 443.8m / Total Assets 802.0m |
(C) -0.02 = EBIT TTM -18.4m / Avg Total Assets 814.3m |
(D) 2.40 = Book Value of Equity 442.8m / Total Liabilities 184.5m |
Total Rating: 6.13 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 28.24
1. Piotroski 3.0pt = -2.0 |
2. FCF Yield 1.16% = 0.58 |
3. FCF Margin 1.85% = 0.46 |
4. Debt/Equity 0.03 = 2.50 |
5. Debt/Ebitda -8.02 = -2.50 |
6. ROIC - WACC -12.70% = -12.50 |
7. RoE -1.09% = -0.18 |
8. Rev. Trend -62.44% = -3.12 |
9. Rev. CAGR -28.45% = -2.50 |
10. EPS Trend data missing |
11. EPS CAGR -28.15% = -2.50 |
As of August 10, 2025, the stock is trading at USD 29.07 with a total of 162,411 shares traded.
Over the past week, the price has changed by -5.28%, over one month by -7.74%, over three months by -3.36% and over the past year by -23.19%.
No, based on ValueRay´s Fundamental Analyses, Marcus & Millichap (NYSE:MMI) is currently (August 2025) a stock to sell. It has a ValueRay Fundamental Rating of 28.24 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MMI is around 25.18 USD . This means that MMI is currently overvalued and has a potential downside of -13.38%.
Marcus & Millichap has received a consensus analysts rating of 1.00. Therefor, it is recommend to sell MMI.
- Strong Buy: 0
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 1
According to our own proprietary Forecast Model, MMI Marcus & Millichap will be worth about 28.4 in August 2026. The stock is currently trading at 29.07. This means that the stock has a potential downside of -2.44%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 30 | 3.2% |
Analysts Target Price | 30 | 3.2% |
ValueRay Target Price | 28.4 | -2.4% |
MMI Fundamental Data Overview
CCE Cash And Equivalents = 139.0m USD (last quarter)
P/S = 1.7644
P/B = 2.0342
P/EG = 1.82
Beta = 1.274
Revenue TTM = 712.0m USD
EBIT TTM = -18.4m USD
EBITDA TTM = -2.34m USD
[93m Long Term Debt = unknown (0.0)
[39m Short Term Debt = 18.8m USD (from shortTermDebt, last quarter)
Debt = 18.8m USD (Calculated: Short Term 18.8m + Long Term 0.0)
Net Debt = -55.1m USD (from netDebt column, last quarter)
Enterprise Value = 1.14b USD (1.26b + Debt 18.8m - CCE 139.0m)
Interest Coverage Ratio = -22.95 (Ebit TTM -18.4m / Interest Expense TTM 800.0k)
FCF Yield = 1.16% (FCF TTM 13.2m / Enterprise Value 1.14b)
FCF Margin = 1.85% (FCF TTM 13.2m / Revenue TTM 712.0m)
Net Margin = -0.95% (Net Income TTM -6.80m / Revenue TTM 712.0m)
Gross Margin = 37.32% ((Revenue TTM 712.0m - Cost of Revenue TTM 446.3m) / Revenue TTM)
Tobins Q-Ratio = 2.57 (Enterprise Value 1.14b / Book Value Of Equity 442.8m)
Interest Expense / Debt = 1.00% (Interest Expense 187.0k / Debt 18.8m)
Taxrate = 21.0% (US default)
NOPAT = -18.4m (EBIT -18.4m, no tax applied on loss)
Current Ratio = 3.77 (Total Current Assets 325.1m / Total Current Liabilities 86.2m)
Debt / Equity = 0.03 (Debt 18.8m / last Quarter total Stockholder Equity 617.6m)
Debt / EBITDA = -8.02 (Net Debt -55.1m / EBITDA -2.34m)
Debt / FCF = 1.43 (Debt 18.8m / FCF TTM 13.2m)
Total Stockholder Equity = 623.2m (last 4 quarters mean)
RoA = -0.85% (Net Income -6.80m, Total Assets 802.0m )
RoE = -1.09% (Net Income TTM -6.80m / Total Stockholder Equity 623.2m)
RoCE = -2.95% (Ebit -18.4m / (Equity 623.2m + L.T.Debt 0.0))
RoIC = -2.95% (NOPAT -18.4m / Invested Capital 623.2m)
WACC = 9.76% (E(1.26b)/V(1.28b) * Re(9.89%)) + (D(18.8m)/V(1.28b) * Rd(1.00%) * (1-Tc(0.21)))
Shares Correlation 5-Years: -70.0 | Cagr: -0.75%
Discount Rate = 9.89% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 57.96% ; FCFE base≈13.2m ; Y1≈7.43m ; Y5≈2.50m
Fair Price DCF = 1.02 (DCF Value 39.6m / Shares Outstanding 39.0m; 5y FCF grow -50.0% → 2.90% )
Revenue Correlation: -62.44 | Revenue CAGR: -28.45%
Revenue Growth Correlation: 93.25%
EPS Correlation: N/A | EPS CAGR: -28.15%
EPS Growth Correlation: 22.10%
Additional Sources for MMI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle